产品名称
Brain PE, Avanti Research™ - A Croda Brand 840022P, powder
SMILES string
[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O
InChI
1S/C41H80NO8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-40(43)47-37-39(38-49-51(45,46)48-36-35-42)50-41(44)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h18,20,39H,3-17,19,21-38,42H2,1-2H3,(H,45,46)/b20-18-/t39-/m1/s1
InChI key
JQKOHRZNEOQNJE-DJEJVYNPSA-N
assay
>99% (TLC)
form
powder
packaging
pkg of 2 × 100 mg (840022P-200mg)
pkg of 1 × 25 mg (840022P-25mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 840022P
lipid type
phosphoglycerides
shipped in
dry ice
storage temp.
−20°C
General description
Contains ~50% plasmalogen ether lipid
Packaging
5 mL Clear Glass Sealed Ampule (840022P-200mg)
5 mL Clear Glass Sealed Ampule (840022P-25mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Application
Brain PE has been used for the preparation of liposomes.
存储类别
11 - Combustible Solids
RIBEYE (B)-domain binds to lipid components of synaptic vesicles in an NAD (H)-dependent, redox-sensitive manner
Schwarz K and Schmitz F
The Biochemical Journal, 474(7), 1205-1220 (2017)
Saurabh Srivastava et al.
PloS one, 10(6), e0130283-e0130283 (2015-06-20)
Recent studies introduced two experimental protocols for converting full-length recombinant prion protein (rPrP) purified from E.coli into the infectious prion state (PrPSc) with high infectivity titers. Both protocols employed protein misfolding cyclic amplification (PMCA) for generating PrPSc de novo, but
Qualitative and quantitative characterization of protein-phosphoinositide interactions with liposome-based methods
Busse RA, et al.
Autophagy, 9(5), 770-777 (2013)
Arupratan Das et al.
Nature cell biology, 14(3), 304-310 (2012-02-22)
Lipid asymmetry at the plasma membrane is essential for such processes as cell polarity, cytokinesis and phagocytosis. Here we find that a lipid flippase complex, composed of Lem3, Dnf1 or Dnf2, has a role in the dynamic recycling of the
Gillian L Dornan et al.
Structure (London, England : 1993), 28(2), 145-156 (2019-12-14)
The class I phosphoinositide 3-kinases (PI3Ks) are key signaling enzymes composed of a heterodimer of a p110 catalytic subunit and a p85 regulatory subunit, with PI3K mutations being causative of multiple human diseases including cancer, primary immunodeficiencies, and developmental disorders.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持